| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.004 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.096 | 0.004 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.008 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.41 | 0.008 |